Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis

Postgraduate Medical Journal

Volumn 78, Issue 915, 2002, Pages 47-48

  Chan, A T Y ^a   Cleeve, V ^a   Daymond, T J ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; DISEASE SEVERITY; DRUG SAFETY; HIP ARTHROPLASTY; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; MALE; NECROTIZING FASCIITIS; PUSTULE; RASH; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEPSIS; SKIN BIOPSY; STREPTOCOCCUS GROUP A; TISSUE NECROSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT, HIP; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; FASCIITIS, NECROTIZING; FATAL OUTCOME; HUMANS; MALE; METHOTREXATE; MIDDLE AGED;

EID: 0036149052     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.915.47     Document Type: Article

References (10)

1. Infliximab and methotrexate in the treatment of rheumatoid arthritis
2. Invasive group A streptococcal infections in Gloucestershire
3. Randomised double blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
4. Infections during low dose methotrexate treatment in RA
5. Opportunistic infection during treatment with low dose methotrexate
6. Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis
7. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase 3 trial
8. Cellular profile and cytokine production prosthesis interfaces - Study of tissues retrieved from revised hip and knee replacements